| Category | Antibody |
| Concentration | pH 7, with 0, 09% sodium azide, 4, In 1X PBS |
| Form | Antigen affinity purified |
| Conjugation | Unconjugated |
| Clone | Polyclonal antibody |
| Recognised antigen | CD55 |
| Host animal | Rabbit (Oryctolagus cuniculus) |
| Clonality | Polyclonal (rabbit origin) |
| Species reactivity | Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications | ELISA, FACS, IF, IHC, WB |
| Recommended dilutions | Flow Cytometry: 1:10-1:50, IHC (Paraffin): 1:10-1:50, Immunofluorescence: 1:10-1:50, Western blot: 1:1000 |
| Notes | Titration of the CD55 antibody may be required due to differences in protocols and secondary/substrate sensitivity |
| Intented use | This CD55 antibodyis to be used only for research purposes and not for diagnostics |
| Uniprot # | P08174 |
| Purity | Antigen affinity |
| Description | Additional, Antigens present on the DAF glycoprotein constitute the Cromer blood group system (CROM), The encoded glycoprotein is also known as the decay-accelerating factor (DAF), The predominant transcript encodes a membrane-bound protein expressed on cells exposed to plasma component proteins but an alternatively spliced transcript produces a soluble protein present at much lower levels, Two alternatively spliced transcripts encoding different proteins have been identified, [provided by RefSeq], alternatively spliced transcript variants have been described, binding of DAF to complement proteins accelerates their decay, but their biological validity has not been determined, disrupting the cascade and preventing damage to host cells, This gene encodes a protein involved in the regulation of the complement cascade |
| Immunogen | A portion of amino acids 51-79 from the human protein was used as the immunogen for this CD55 antibody |
| Storage | Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot the CD55 antibody and store frozen at -20 deg |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target | CD55 |
| Short name | CD55 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | decay accelerating factor to measure complement (Cromer blood group) (Antibody to), CD55 molecule |
| Alternative technique | antibodies |
| Alternative to gene target | CD55 and IDBG-106331 and ENSG00000196352 and 1604, CD55 and IDBG-629269 and ENSBTAG00000006984 and 518609, CR and CROM and DAF and TC, Extracellular, alpha-beta T cell activation and biological process this GO :2000563 and positive regulation of CD4-positive, alpha-beta T cell cytokine production and biological process this GO :0043086 and negative regulation of catalytic activity and biological process this GO :0043434 and response to peptide hormone and biological process this GO :0045087 and innate immune response and biological process this GO :0045121 and membrane raft and cellular component this GO :0045730 and respiratory burst and biological process this GO :0045916 and negative regulation of complement activation and biological process this GO :0060137 and maternal process involved in parturition and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :2000516 and positive regulation of CD4-positive, alpha-beta T cell proliferation and biological process, classical pathway and biological process this GO :0007204 and positive regulation of cytosolic calcium ion concentration and biological process this GO :0007283 and spermatogenesis and biological process this GO :0008289 and lipid binding and molecular function this GO :0009615 and response to virus and biological process this GO :0009986 and cell surface and cellular component this GO :0016324 and apical plasma membrane and cellular component this GO :0030449 and regulation of complement activation and biological process this GO :0031225 and anchored component of membrane and cellular component this GO :0031664 and regulation of lipopolysaccharide-mediated signaling pathway and biological process this GO :0035743 and CD4-positive, decay accelerating factor for complement (Cromer blood group), lipid binding, this GO :0001618 and virus receptor activity and molecular function this GO :0004857 and enzyme inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006958 and complement activation, this GO :0001618: virus receptor activity, this GO :0001618: virus receptor activity and also this GO :0004857: enzyme inhibitor activity and also this GO :0005515: protein binding and also this GO :0008289: lipid binding, this GO :0004857: enzyme inhibitor activity, this GO :0005515: protein binding, this GO :0008289: lipid binding, CD55 molecule |
| Identity | 2665 |
| Gene | CD55 |
| Long gene name | CD55 molecule (Cromer blood group) |
| Synonyms gene | DAF |
| Synonyms gene name | Cromer blood group system) CD55 molecule, decay accelerating factor for complement (CD55, decay accelerating factor for complement (Cromer blood group) |
| Synonyms | CR TC CROM |
| Locus | 1q32, 2 |
| Discovery year | 2001-06-22 |
| GenBank acession | BC001288 |
| Entrez gene record | 1604 |
| RefSeq identity | NM_000574 |
| Classification | Sushi domain containing CD molecules Blood group antigens |
| Havana BLAST/BLAT | OTTHUMG00000036255 |
| Locus Specific Databases | Blood Group Antigen Mutation Database CD55base: Mutation registry for Decay-accelerating factor (CD55) deficiency (previously known as DAFbase) LRG_127 |